Recurrent Clostridium difficile

被引：116

作者：

Maroo, S ^{[1
]}

Lamont, JT ^{[1
]}

机构：

[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA

来源：

GASTROENTEROLOGY | 2006年 / 130卷 / 04期

关键词：

D O I：

10.1053/j.gastro.2006.02.044

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：1311 / 1316

页数：6

共 47 条

[1] Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube [J].

Aas, J ;

Gessert, CE ;

Bakken, JS .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (05) :580-585

[2] Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A [J].

Aboudola, S ;

Kotloff, KL ;

Kyne, L ;

Warny, M ;

Kelly, EC ;

Sougioultzis, S ;

Giannasca, PJ ;

Monath, TP ;

Kelly, CP .

INFECTION AND IMMUNITY, 2003, 71 (03) :1608-1610

[3]

BARTLETT JG, 1980, GASTROENTEROLOGY, V78, P431

[4] THERAPY OF RELAPSING CLOSTRIDIUM-DIFFICILE ASSOCIATED DIARRHEA AND COLITIS WITH THE COMBINATION OF VANCOMYCIN AND RIFAMPIN [J].

BUGGY, BP ;

FEKETY, R ;

SILVA, J .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 1987, 9 (02) :155-159

[5] Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis [J].

Cherifi, S ;

Robberecht, J ;

Miendje, Y .

ACTA CLINICA BELGICA, 2004, 59 (04) :223-224

[6] DIMINISHED CLOSTRIDIUM-DIFFICILE TOXIN-A SENSITIVITY IN NEWBORN RABBIT ILEUM IS ASSOCIATED WITH DECREASED TOXIN-A RECEPTOR [J].

EGLOW, R ;

POTHOULAKIS, C ;

ITZKOWITZ, S ;

ISRAEL, EJ ;

OKEANE, CJ ;

GONG, DH ;

GAO, N ;

XU, YL ;

WALKER, WA ;

LAMONT, JT .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :822-829

[7] Biotherapeutic agents - A neglected modality for the treatment and prevention of selected intestinal and vaginal infections [J].

Elmer, GW ;

Surawicz, CM ;

McFarland, LV .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11) :870-876

[8]

Fekety R, 1997, AM J GASTROENTEROL, V92, P739

[9] Recurrent Clostridium difficile diarrhea: Characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial [J].

Fekety, R ;

McFarland, LV ;

Surawicz, CM ;

Greenberg, RN ;

Elmer, GW ;

Mulligan, ME .

CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) :324-333

[10]

GORBACH SL, 1987, LANCET, V2, P1519

← 1 2 3 4 5 →